CL-108

DRUG3 trials

Sponsors

Charleston Laboratories, Inc

Conditions

HealthyNauseaPainVomiting

Phase 1

A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

CompletedNCT02465866

Charleston Laboratories, IncHealthy

Start: 2014-11-30End: 2015-04-30Updated: 2017-05-02

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

CompletedNCT02712554

Charleston Laboratories, IncNausea, Pain, Vomiting

Start: 2015-06-30End: 2015-09-30Updated: 2019-10-14

Phase 3

A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip

CompletedNCT02462850

Charleston Laboratories, IncNausea, Pain, Vomiting

Start: 2014-10-31End: 2015-02-28Updated: 2016-11-03